Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Multiple sclerosis rubella:

Search results

Items: 1 to 20 of 207

1.

G1m1 predominance of intrathecal virus-specific antibodies in multiple sclerosis.

Tomescu-Baciu A, Vartdal F, Holmøy T, Vedeler CA, Lossius A.

Ann Clin Transl Neurol. 2018 Sep 17;5(10):1303-1309. doi: 10.1002/acn3.642. eCollection 2018 Oct.

2.

The intrathecal polyspecific antiviral immune response (MRZ reaction): A potential cerebrospinal fluid marker for multiple sclerosis diagnosis.

Feki S, Gargouri S, Mejdoub S, Dammak M, Hachicha H, Hadiji O, Feki L, Hammami A, Mhiri C, Karray H, Masmoudi H.

J Neuroimmunol. 2018 Aug 15;321:66-71. doi: 10.1016/j.jneuroim.2018.05.015. Epub 2018 May 28.

PMID:
29957390
3.

The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.

Hottenrott T, Schorb E, Fritsch K, Dersch R, Berger B, Huzly D, Rauer S, Tebartz van Elst L, Endres D, Stich O.

J Neurol. 2018 May;265(5):1106-1114. doi: 10.1007/s00415-018-8779-x. Epub 2018 Mar 6.

PMID:
29511863
4.

The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosis.

Hottenrott T, Dersch R, Berger B, Endres D, Huzly D, Thiel J, Rauer S, Stich O, Salzer U, Venhoff N.

BMC Neurol. 2018 Jan 31;18(1):14. doi: 10.1186/s12883-018-1018-3.

5.

Do patients with schizophreniform and bipolar disorders show an intrathecal, polyspecific, antiviral immune response? A pilot study.

Endres D, Huzly D, Dersch R, Stich O, Berger B, Schuchardt F, Perlov E, Venhoff N, Hellwig S, Fiebich BL, Erny D, Hottenrott T, Tebartz van Elst L.

Fluids Barriers CNS. 2017 Dec 7;14(1):34. doi: 10.1186/s12987-017-0082-1.

6.

Low intrathecal antibody production despite high seroprevalence of Epstein-Barr virus in multiple sclerosis: a review of the literature.

Ruprecht K, Wildemann B, Jarius S.

J Neurol. 2018 Feb;265(2):239-252. doi: 10.1007/s00415-017-8656-z. Epub 2017 Nov 2. Review.

PMID:
29098417
7.

Vaccines to Children: Protective Effect and Adverse Events: A Systematic Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2009 Feb.

8.

Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.

Jarius S, König FB, Metz I, Ruprecht K, Paul F, Brück W, Wildemann B.

J Neuroinflammation. 2017 Aug 29;14(1):171. doi: 10.1186/s12974-017-0929-z.

10.

The MRZ reaction in primary progressive multiple sclerosis.

Hottenrott T, Dersch R, Berger B, Rauer S, Huzly D, Stich O.

Fluids Barriers CNS. 2017 Feb 7;14(1):2. doi: 10.1186/s12987-016-0049-7.

11.

The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Jarius S, Eichhorn P, Franciotta D, Petereit HF, Akman-Demir G, Wick M, Wildemann B.

J Neurol. 2017 Mar;264(3):453-466. doi: 10.1007/s00415-016-8360-4. Epub 2016 Dec 22. Review.

PMID:
28005176
12.

MRZH reaction increases sensitivity for intrathecal IgG synthesis in IgG Oligoclonal band negative Multiple Sclerosis patients.

Dias-Carneiro RP, von Glehn F, Moraes AS, Boldrini VO, Damasceno A, Andrade MD, Lima AC, Casanova CS, Tilbery CP, Damasceno BP, Santos LM, Brandão CO.

J Neuroimmunol. 2016 Nov 15;300:30-35. doi: 10.1016/j.jneuroim.2016.10.001. Epub 2016 Oct 5.

PMID:
27806873
13.

Correlation between anti-JC-virus and anti-cytomegalovirus, -Epstein-Barr virus and -measles/-rubella/-varicella-zoster-virus antibodies.

Auer M, Borena W, Holm-von Laer D, Deisenhammer F.

J Med Virol. 2017 Jan;89(1):3-9. doi: 10.1002/jmv.24590. Epub 2016 Jun 9.

PMID:
27253624
14.

Validation of a multiplexing technique to determine the intrathecal, polyspecific antiviral immune response in multiple sclerosis.

Huss A, Buttmann M, Brecht I, Weishaupt A, Otto M, Tumani H.

Expert Rev Mol Diagn. 2016 Dec;16(12):1353-1356. Epub 2016 Oct 31.

PMID:
27759441
15.

Vaccines and multiple sclerosis: a systematic review.

Mailand MT, Frederiksen JL.

J Neurol. 2017 Jun;264(6):1035-1050. doi: 10.1007/s00415-016-8263-4. Epub 2016 Sep 7. Review.

PMID:
27604618
16.

Frequency of viral infections and environmental factors in multiple sclerosis.

Eftekharian MM, Ghannad MS, Taheri M, Roshanaei G, Mazdeh M, Musavi M, Hormoz MB.

Hum Antibodies. 2016 Jun 8;24(1-2):17-23. doi: 10.3233/HAB-150289.

PMID:
27472869
17.

Dietary Inflammatory Index and Risk of Multiple Sclerosis in a Case-Control Study from Iran.

Shivappa N, Hebert JR, Behrooz M, Rashidkhani B.

Neuroepidemiology. 2016;47(1):26-31. doi: 10.1159/000445874. Epub 2016 Jul 1.

18.

Unilateral Optic Neuritis: A Rare Complication after Measles-Mumps-Rubella Vaccination in a 30-Year-Old Woman.

De Giacinto C, Guaglione E, Leon PE, D'Aloisio R, Vattovani O, Ravalico G, Tognetto D.

Case Rep Ophthalmol Med. 2016;2016:8740264. doi: 10.1155/2016/8740264. Epub 2016 Apr 19.

20.

The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort.

Hottenrott T, Dersch R, Berger B, Rauer S, Eckenweiler M, Huzly D, Stich O.

Fluids Barriers CNS. 2015 Dec 13;12:27. doi: 10.1186/s12987-015-0024-8.

Supplemental Content

Loading ...
Support Center